Internal Medicine·Edinburg, TX

Doctors Hospital at Renaissance, Ltd.

Signal lift22%64%+42 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
220–253
p10 – p90
Sample N
3,249
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
0.3%
11 of 3,249 applicants
01Cohort funnelthis cycle
N = 3,249
Applied
3,249
100.0%
Invited
106
3.3%
Class size
11
0.3%
J-1 visaAny graduation yearCategorical
Your fitDoctors Hospital at Renaissance, Ltd. Program

Create a free profile to see your personalized fit

Get started

Who to contact

Training sites1 site · Edinburg
  • 1
    Doctors Hospital at Renaissance Ltd
    Edinburg, TX
    Primary
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK220 – 253
180205230255280

Level 2 CE data not available

Interview rates
US MD
8%
US DO
2%
US IMG
4%
Non-US IMG
3%
Signal rates
Gold
53%
Silver
13%
None
0%
Applicant origin
In-state
9%
Out-of-state
3%
Interview prepInternal Medicine
specialtyWhy internal medicine over family medicine?★ common
specialtyAre you interested in subspecializing? Which fellowship?★ common
clinicalDescribe a complex diagnostic case you've worked through.★ common
clinicalHow do you approach a patient with multiple comorbidities?
clinicalWhat's your approach to evidence-based medicine?
programAcademic vs community — what setting do you prefer?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesInternal Medicine · 25-26
Save this program

Add Doctors Hospital at Renaissance, Ltd. to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Internal Medicine.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.